| Basics |
Novo-Nordisk A/S
Novo Nordisk A/S is a healthcare company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The company's business segments include, diabetes and obesity care, and biopharmaceuticals.
|
| IPO Date: |
April 1, 1981 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$245.41B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.58 | 0.72%
|
| Avg Daily Range (30 D): |
$0.57 | 1.04%
|
| Avg Daily Range (90 D): |
$0.77 | 1.18%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.34M |
| Avg Daily Volume (30 D): |
21.85M |
| Avg Daily Volume (90 D): |
13.4M |
| Trade Size |
| Avg Trade Size (Sh.): |
101 |
| Avg Trade Size (Sh.) (30 D): |
108 |
| Avg Trade Size (Sh.) (90 D): |
98 |
| Institutional Trades |
| Total Inst.Trades: |
23,396 |
| Avg Inst. Trade: |
$4.34M |
| Avg Inst. Trade (30 D): |
$3.72M |
| Avg Inst. Trade (90 D): |
$3.91M |
| Avg Inst. Trade Volume: |
.13M |
| Avg Inst. Trades (Per Day): |
6 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.2M |
| Avg Closing Trade (30 D): |
$34.88M |
| Avg Closing Trade (90 D): |
$25M |
| Avg Closing Volume: |
95.43K |
|
|
| Splits |
|
Sep 20, 2023:
2:1
|
|
Jan 09, 2014:
5:1
|
|
Dec 17, 2007:
2:1
|
|
Apr 11, 2001:
5:2
|
|
|
|
